Specific diagnosis of progressive multifocal leukoencephalopathy by polymerase chain reaction. 1994

T Weber, and R W Turner, and S Frye, and B Ruf, and J Haas, and E Schielke, and H D Pohle, and W Lüke, and W Lüer, and K Felgenhauer
Neurologische Klinik und Poliklinik, Georg-August-Universität, Göttingen, Germany.

Using polymerase chain reaction (PCR), 34 cerebrospinal fluid (CSF) samples from 28 patients with progressive multifocal leukoencephalopathy (PML) were analyzed. As controls, 116 samples were evaluated from 82 human immunodeficiency virus type 1 (HIV-1)-infected patients and 1 HIV-1-negative patient. Of the HIV-1-positive patients, 23 had cerebral toxoplasmosis, 10 had HIV leukoencephalopathy, and 49 had other neurologic complications. Detection of JC virus (JCV) DNA in CSF was increased 10-fold by the addition of carrier DNA before phenol-chloroform-isoamyl alcohol extraction. The primer pair JC 26/29, from the VP1/large T region, had a limit of detection of 10(5) JCV DNA molecules/100 microL. The primer pair JC 36/39, located in the large T gene region, had a 100-fold lower limit of detection. With JC 26/29, the sensitivity was 43% (12/28) and specificity was 100%. Using JC 36/39, sensitivity increased to 82% (23/28), and false-positive results were not observed. Diagnosis of PML is greatly aided by PCR analysis of CSF.

UI MeSH Term Description Entries
D007968 Leukoencephalopathy, Progressive Multifocal An opportunistic viral infection of the central nervous system associated with conditions that impair cell-mediated immunity (e.g., ACQUIRED IMMUNODEFICIENCY SYNDROME and other IMMUNOLOGIC DEFICIENCY SYNDROMES; HEMATOLOGIC NEOPLASMS; IMMUNOSUPPRESSION; and COLLAGEN DISEASES). The causative organism is JC Polyomavirus (JC VIRUS) which primarily affects oligodendrocytes, resulting in multiple areas of demyelination. Clinical manifestations include DEMENTIA; ATAXIA; visual disturbances; and other focal neurologic deficits, generally progressing to a vegetative state within 6 months. (From Joynt, Clinical Neurology, 1996, Ch26, pp36-7) Encephalitis, JC Polyomavirus,Progressive Multifocal Leukoencephalopathy,JC Polyomavirus Encephalopathy,Encephalopathies, JC Polyomavirus,Encephalopathy, JC Polyomavirus,JC Polyomavirus Encephalitis,Leukoencephalopathies, Progressive Multifocal,Multifocal Leukoencephalopathies, Progressive,Multifocal Leukoencephalopathy, Progressive,Progressive Multifocal Leukoencephalopathies
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011120 Polyomavirus A genus of potentially oncogenic viruses of the family POLYOMAVIRIDAE. These viruses are normally present in their natural hosts as latent infections. The virus is oncogenic in hosts different from the species of origin. Bovine polyomavirus,Murine polyomavirus,Hamster polyomavirus,Polyoma Virus,Polyoma Viruses,Bovine polyomaviruses,Hamster polyomaviruses,Murine polyomaviruses,Polyomaviruses,Virus, Polyoma,Viruses, Polyoma,polyomavirus, Hamster,polyomaviruses, Bovine,polyomaviruses, Murine
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain

Related Publications

T Weber, and R W Turner, and S Frye, and B Ruf, and J Haas, and E Schielke, and H D Pohle, and W Lüke, and W Lüer, and K Felgenhauer
January 1995, Acta cytologica,
T Weber, and R W Turner, and S Frye, and B Ruf, and J Haas, and E Schielke, and H D Pohle, and W Lüke, and W Lüer, and K Felgenhauer
October 1990, The Journal of infectious diseases,
T Weber, and R W Turner, and S Frye, and B Ruf, and J Haas, and E Schielke, and H D Pohle, and W Lüke, and W Lüer, and K Felgenhauer
October 2019, BMC neurology,
T Weber, and R W Turner, and S Frye, and B Ruf, and J Haas, and E Schielke, and H D Pohle, and W Lüke, and W Lüer, and K Felgenhauer
July 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
T Weber, and R W Turner, and S Frye, and B Ruf, and J Haas, and E Schielke, and H D Pohle, and W Lüke, and W Lüer, and K Felgenhauer
March 1992, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
T Weber, and R W Turner, and S Frye, and B Ruf, and J Haas, and E Schielke, and H D Pohle, and W Lüke, and W Lüer, and K Felgenhauer
December 1981, Die Medizinische Welt,
T Weber, and R W Turner, and S Frye, and B Ruf, and J Haas, and E Schielke, and H D Pohle, and W Lüke, and W Lüer, and K Felgenhauer
October 1994, Annals of neurology,
T Weber, and R W Turner, and S Frye, and B Ruf, and J Haas, and E Schielke, and H D Pohle, and W Lüke, and W Lüer, and K Felgenhauer
January 1977, Radiology,
T Weber, and R W Turner, and S Frye, and B Ruf, and J Haas, and E Schielke, and H D Pohle, and W Lüke, and W Lüer, and K Felgenhauer
January 2013, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova,
T Weber, and R W Turner, and S Frye, and B Ruf, and J Haas, and E Schielke, and H D Pohle, and W Lüke, and W Lüer, and K Felgenhauer
January 2001, American clinical laboratory,
Copied contents to your clipboard!